Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Gut
|
September 1, 1986
Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer
C W Howden, D B Jones, D W Burget, et al.
Scandinavian Journal of Gastroenterology
|
August 1, 1986
The effect of temperature and pH on the stability of human pepsin in stored gastric juice. A method to prevent activity loss
C J de Gara, D W Burget, T Sivakumaran, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 1989
Does misoprostol given as a single large dose improve its antisecretory effect?
S G Chiverton, D W Burget, B J Salena, et al.
Gut
|
July 1, 1988
Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist
D B Jones, C W Howden, D W Burget, et al.
Digestive Diseases and Sciences
|
May 1, 1988
The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates
C W Howden, D B Jones, K E Peace, et al.
Gut
|
September 1, 1987
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs
D B Jones, C W Howden, D W Burget, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 1987
The effects of intravenous famotidine on pentagastrin-stimulated gastric secretion in man
C J De Gara, D W Burget, A N Chremos, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1986
The correlation between acid suppression and peptic ulcer healing
R H Hunt, C W Howden, D B Jones, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 1987
Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue
C W Howden, D W Burget, C Silletti, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Gut
|
September 1, 1986
Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer
C W Howden, D B Jones, D W Burget, et al.
Scandinavian Journal of Gastroenterology
|
August 1, 1986
The effect of temperature and pH on the stability of human pepsin in stored gastric juice. A method to prevent activity loss
C J de Gara, D W Burget, T Sivakumaran, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 1989
Does misoprostol given as a single large dose improve its antisecretory effect?
S G Chiverton, D W Burget, B J Salena, et al.
Gut
|
July 1, 1988
Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist
D B Jones, C W Howden, D W Burget, et al.
Digestive Diseases and Sciences
|
May 1, 1988
The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates
C W Howden, D B Jones, K E Peace, et al.
Gut
|
September 1, 1987
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs
D B Jones, C W Howden, D W Burget, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 1987
The effects of intravenous famotidine on pentagastrin-stimulated gastric secretion in man
C J De Gara, D W Burget, A N Chremos, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1986
The correlation between acid suppression and peptic ulcer healing
R H Hunt, C W Howden, D B Jones, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 1987
Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue
C W Howden, D W Burget, C Silletti, et al.
Page
of 2